Screener
Nuvation Bio NUVB Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's retained earnings?
- Nuvation Bio (NUVB) reported retained earnings of -$1.17B in Q2 2026.
- How has Nuvation Bio's retained earnings changed year-over-year?
- Nuvation Bio's retained earnings decreased by 14.6% year-over-year, from -$1.02B to -$1.17B.
- What is the long-term trend for Nuvation Bio's retained earnings?
- Over 5 years (2020 to 2025), Nuvation Bio's retained earnings has grown at a 71.1% compound annual growth rate (CAGR), from -$75.96M to -$1.12B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Nuvation Bio's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude